表紙:バイオチップの世界市場 (2021-2026年):産業動向・市場シェア・市場規模・成長予測・市場機会
市場調査レポート
商品コード
1029128

バイオチップの世界市場 (2021-2026年):産業動向・市場シェア・市場規模・成長予測・市場機会

Biochips Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 146 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=116.46円
バイオチップの世界市場 (2021-2026年):産業動向・市場シェア・市場規模・成長予測・市場機会
出版日: 2021年09月16日
発行: IMARC Services Private Limited
ページ情報: 英文 146 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバイオチップの市場規模は予測期間中約15%のCAGRで成長すると予測されています。

バイオチップは主に、創薬、体外診断、遺伝子発現プロファイリング、一塩基多型のジェノタイピング、農業バイオテクノロジーなどに使用されており、さまざまな製薬企業、バイオテクノロジー企業、研究機関、大学の研究所、医療施設などで広く採用されています。

慢性疾患の増加や高齢者の増加が同市場の成長を推進しています。最近では、癌の発生率の増加から、体内の癌細胞を早期に発見するためのバイオチップの使用が増加しています。また、ウイルス感染や免疫疾患に対する消費者の関心が高まっていることも、バイオチップを用いた創薬・開発の需要を押し上げています。新型コロナウイルス感染症 (COVID-19) の世界的流行を受け、いくつかのバイオテクノロジー企業や製薬企業は、体内の感染を検出するための新しいバイオチップの開発に注力しています。

当レポートでは、世界のバイオチップの市場を調査し、市場の定義と概要、バリューチェーン、新型コロナウイルス感染症 (COVID-19)およびその他の市場影響因子の分析、市場規模の推移・予測、製品タイプ・製造技術・分析手法・用途・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 序文

第2章 調査範囲・調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界市場の動向

  • 市場概要
  • 市場実績
  • COVID-19の影響

第6章 市場分析・予測:製品タイプ別

  • DNAチップ
  • プロテインチップ
  • Lab-On-a-Chip
  • 酵素チップ

第7章 市場分析・予測:製造技術別

  • マイクロアレイ
  • マイクロ流体

第8章 市場分析・予測:分析手法別

  • 電気泳動
  • 発光
  • 質量分析
  • 電気信号
  • 磁気

第9章 市場分析・予測:用途別

  • 分子分析
    • ハイブリダイゼーション
    • タンパク質
    • 免疫学的分析
    • 生体分子
    • バイオマーカー
    • その他
  • 診断
    • 遺伝子診断
    • 腫瘍
    • 炎症性疾患
    • その他
  • 非生物学的使用法

第10章 市場分析・予測:エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 病院・診断センター
  • 学術・研究機関
  • その他

第11章 市場分析・予測:地域・主要国別

  • 北米
  • アジア太平洋
  • 欧州
  • ラテンアメリカ
  • 中東・アフリカ

第12章 SWOT分析

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies, Inc.
    • bioMerieux SA
    • Bio-RAD Laboratories, Inc.
    • CapitalBio Corporation
    • Dynamic Biosensors GmbH
    • EMD Millipore Corporation
    • Fluidigm Corporation
    • Illumina, Inc.
    • Perkinelmer, Inc.
    • Thermo Fisher Scientific, Inc.
図表

List of Figures

  • Figure 1: Global: Biochips Market: Major Drivers and Challenges
  • Figure 2: Global: Biochips Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: Biochips Market: Breakup by Product Type (in %), 2020
  • Figure 4: Global: Biochips Market: Breakup by Fabrication Technique (in %), 2020
  • Figure 5: Global: Biochips Market: Breakup by Analysis Method (in %), 2020
  • Figure 6: Global: Biochips Market: Breakup by Application (in %), 2020
  • Figure 7: Global: Biochips Market: Breakup by End User (in %), 2020
  • Figure 8: Global: Biochips Market: Breakup by Region (in %), 2020
  • Figure 9: Global: Biochips Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 10: Global: Biochips Market (DNA Chip) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 11: Global: Biochips Market (DNA Chip) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 12: Global: Biochips Market (Protein Chip) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 13: Global: Biochips Market (Protein Chip) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 14: Global: Biochips Market (Lab-On-a-Chip) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 15: Global: Biochips Market (Lab-On-a-Chip) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 16: Global: Biochips Market (Enzyme Chip) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 17: Global: Biochips Market (Enzyme Chip) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 18: Global: Biochips Market (Microarray) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 19: Global: Biochips Market (Microarray) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 20: Global: Biochips Market (Microfluidic) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 21: Global: Biochips Market (Microfluidic) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 22: Global: Biochips Market (Electrophoresis) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 23: Global: Biochips Market (Electrophoresis) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 24: Global: Biochips Market (Luminescence) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 25: Global: Biochips Market (Luminescence) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 26: Global: Biochips Market (Mass Spectrometry) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 27: Global: Biochips Market (Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 28: Global: Biochips Market (Electrical Signals) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 29: Global: Biochips Market (Electrical Signals) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 30: Global: Biochips Market (Magnetism) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 31: Global: Biochips Market (Magnetism) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 32: Global: Biochips Market (Molecular Analysis) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 33: Global: Biochips Market (Molecular Analysis) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 34: Global: Biochips Market (Hybridization) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 35: Global: Biochips Market (Hybridization) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 36: Global: Biochips Market (Protein) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 37: Global: Biochips Market (Protein) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 38: Global: Biochips Market (Immunological) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 39: Global: Biochips Market (Immunological) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 40: Global: Biochips Market (Biomolecules) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 41: Global: Biochips Market (Biomolecules) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 42: Global: Biochips Market (Biomarker) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 43: Global: Biochips Market (Biomarker) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 44: Global: Biochips Market (Others) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 45: Global: Biochips Market (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 46: Global: Biochips Market (Diagnosis) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 47: Global: Biochips Market (Diagnosis) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 48: Global: Biochips Market (Gene Diagnosis) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 49: Global: Biochips Market (Gene Diagnosis) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 50: Global: Biochips Market (Oncology) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 51: Global: Biochips Market (Oncology) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 52: Global: Biochips Market (Inflammatory) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 53: Global: Biochips Market (Inflammatory) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 54: Global: Biochips Market (Others) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 55: Global: Biochips Market (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 56: Global: Biochips Market (Non-Biological Usage) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 57: Global: Biochips Market (Non-Biological Usage) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 58: Global: Biochips Market (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 59: Global: Biochips Market (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 60: Global: Biochips Market (Hospitals and Diagnostics Centers) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 61: Global: Biochips Market (Hospitals and Diagnostics Centers) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 62: Global: Biochips Market (Academic & Research Institutes) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 63: Global: Biochips Market (Academic & Research Institutes) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 64: Global: Biochips Market (Others) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 65: Global: Biochips Market (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 66: North America: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 67: North America: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 68: United States: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 69: United States: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 70: Canada: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 71: Canada: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 72: Europe: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 73: Europe: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 74: Germany: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 75: Germany: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 76: France: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 77: France: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 78: United Kingdom: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 79: United Kingdom: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 80: Spain: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 81: Spain: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 82: Russia: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 83: Russia: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 84: Italy: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 85: Italy: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 86: Others: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 87: Others: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 88: Asia Pacific: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 89: Asia Pacific: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 90: China: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 91: China: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 92: India: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 93: India: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 94: Japan: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 95: Japan: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 96: South Korea: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 97: South Korea: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 98: Australia: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 99: Australia: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 100: Others: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 101: Others: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 102: Latin America: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 103: Latin America: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 104: Mexico: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 105: Mexico: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 106: Brazil: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 107: Brazil: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 108: Argentina: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 109: Argentina: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 110: Others: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 111: Others: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 112: Middle East and Africa: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 113: Middle East and Africa: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 114: Turkey: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 115: Turkey: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 116: Saudi Arabia: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 117: Saudi Arabia: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 118: United Arab Emirates: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 119: United Arab Emirates: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 120: Others: Biochips Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 121: Others: Biochips Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 122: Global: Biochips Industry: SWOT Analysis
  • Figure 123: Global: Biochips Industry: Value Chain Analysis
  • Figure 124: Global: Biochips Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biochips Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Biochips Market Forecast: Breakup by Product Type (in Million US$), 2021-2026
  • Table 3: Global: Biochips Market Forecast: Breakup by Fabrication Technique (in Million US$), 2021-2026
  • Table 4: Global: Biochips Market Forecast: Breakup by Analysis Method (in Million US$), 2021-2026
  • Table 5: Global: Biochips Market Forecast: Breakup by Application (in Million US$), 2021-2026
  • Table 6: Global: Biochips Market Forecast: Breakup by End User (in Million US$), 2021-2026
  • Table 7: Global: Biochips Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 8: Global: Biochips Market: Competitive Structure
  • Table 9: Global: Biochips Market: Key Players
目次
Product Code: SR1020F78_Report

The global biochips market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 15% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.

Biochips refer to a miniaturized medical device that includes a wide collection of microarrays for performing multiple biochemical reactions simultaneously. They contain numerous biosensors that enable the screening of several biological analytes such as enzymes, proteins, DNA, biological molecules, antibodies, etc. Biochips are primarily used in drug discovery, in-vitro diagnostics, gene expression profiling, single nucleotide polymorphism genotyping, agricultural biotechnology, etc. As a result, they are widely adopted across various pharmaceutical and biotechnology companies, research and academic laboratories, and healthcare facilities. The increasing prevalence of chronic disorders along with the rising geriatric population is currently driving the demand for biochips in the medical sector. In recent times, the growing incidences of cancer have also augmented the use of biochips for the early detection of cancerous cells in the body. In line with this, biochips are increasingly being adopted for developing targeted and personalized medicines for cancer treatment. Additionally, the growing consumer health concerns towards several viral infections and immunological disorders are also propelling the demand for biochips in new drug discovery and development activities. For instance, with the outbreak of the COVID-19 pandemic, several biotechnology and pharma companies are focusing on developing novel biochips for detecting the infection in the body. Moreover, rising advancements in microfluid technology have led to the introduction of specifically engineered biochips for various laboratory procedures. Furthermore, numerous R&D activities in the biotechnology sector have also led to the emergence of digital microfluidic biochips. The changing consumer inclination towards minimally invasive surgeries coupled with rising upgradations in nanotechnology are further driving the demand for biochips. Apart from this, the growing investments in the healthcare sector pertaining to cancer genomics, human proteome, and DNA-analysis are further anticipated to catalyze the global biochips market.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global biochips market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product type, fabrication technique, analysis method, application and end user.

Breakup by Product Type:

  • DNA Chip
  • Protein Chip
  • Lab-On-a-Chip
  • Enzyme Chip

Breakup by Fabrication Technique:

  • Microarray
  • Microfluidic

Breakup by Analysis Method:

  • Electrophoresis
  • Luminescence
  • Mass Spectrometry
  • Electrical Signals
  • Magnetism

Breakup by Application:

  • Molecular Analysis
  • Hybridization
  • Protein
  • Immunological
  • Biomolecules
  • Biomarker
  • Others
  • Diagnosis
  • Gene Diagnosis
  • Oncology
  • Inflammatory
  • Others
  • Non-Biological Usage

Breakup by End User:

  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Diagnostics Centers
  • Academic & Research Institutes
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Russia
  • Italy
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Others
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Others
  • Middle East and Africa
  • Turkey
  • Saudi Arabia
  • United Arab Emirates
  • Others

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies, Inc., bioMerieux SA, Bio-RAD Laboratories, Inc., CapitalBio Corporation, Dynamic Biosensors GmbH, EMD Millipore Corporation, Fluidigm Corporation, Illumina, Inc., Perkinelmer, Inc., and Thermo Fisher Scientific Inc. Key Questions Answered in This Report:

  • How has the global biochips market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global biochips market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the fabrication technique?
  • What is the breakup of the market based on the analysis method?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the market?
  • What is the structure of the global biochips market and who are the key players?
  • What is the degree of competition in the market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biochips Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 DNA Chip
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Protein Chip
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Lab-On-a-Chip
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Enzyme Chip
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Fabrication Technique

  • 7.1 Microarray
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Microfluidic
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Analysis Method

  • 8.1 Electrophoresis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Luminescence
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Mass Spectrometry
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Electrical Signals
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Magnetism
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Molecular Analysis
    • 9.1.1 Hybridization
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Protein
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
    • 9.1.3 Immunological
      • 9.1.3.1 Market Trends
      • 9.1.3.2 Market Forecast
    • 9.1.4 Biomolecules
      • 9.1.4.1 Market Trends
      • 9.1.4.2 Market Forecast
    • 9.1.5 Biomarker
      • 9.1.5.1 Market Trends
      • 9.1.5.2 Market Forecast
    • 9.1.6 Others
      • 9.1.6.1 Market Trends
      • 9.1.6.2 Market Forecast
  • 9.2 Diagnosis
    • 9.2.1 Gene Diagnosis
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Oncology
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 Inflammatory
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 Others
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
  • 9.3 Non-Biological Usage
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Pharmaceutical and Biotechnology Companies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals and Diagnostics Centers
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Academic & Research Institutes
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Europe
    • 11.2.1 Germany
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 France
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 United Kingdom
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 Spain
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Russia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Italy
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Asia Pacific
    • 11.3.1 China
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 India
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 Japan
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 South Korea
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Australia
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Others
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Mexico
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Brazil
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Argentina
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
    • 11.4.4 Others
      • 11.4.4.1 Market Trends
      • 11.4.4.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Turkey
      • 11.5.1.1 Market Trends
      • 11.5.1.2 Market Forecast
    • 11.5.2 Saudi Arabia
      • 11.5.2.1 Market Trends
      • 11.5.2.2 Market Forecast
    • 11.5.3 United Arab Emirates
      • 11.5.3.1 Market Trends
      • 11.5.3.2 Market Forecast
    • 11.5.4 Others
      • 11.5.4.1 Market Trends
      • 11.5.4.2 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies, Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 bioMerieux SA
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bio-RAD Laboratories, Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 CapitalBio Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Dynamic Biosensors GmbH
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 EMD Millipore Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Fluidigm Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Illumina, Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Perkinelmer, Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Thermo Fisher Scientific, Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis